GlassScriptPhysician profile
Felix Rios Gonzalez
NPI 1962411835
$3,949.86
in general payments reported to CMS, 2019-2025
14 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,711 · 2020: $202 · 2021: $636 · 2022: $218 · 2023: $465 · 2024: $442 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,458.47 | 2019-2024 | Xience Skypoint, Optis |
| Janssen Pharmaceuticals, INC | $596.55 | 2019-2024 | Xarelto, Invokana |
| E.R. Squibb & Sons, L.L.C. | $363.43 | 2019-2023 | Eliquis |
| Amgen INC. | $360.46 | 2019-2025 | Repatha, Repatha |
| Medtronic, INC. | $280.97 | 2021-2024 | Symplicity G3, Corevalve Evolut R |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.86 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $195.55 | 2019-2025 | Farxiga, Lokelma |
| Chiesi USA, INC. | $131.65 | 2019-2021 | |
| Medtronic Vascular, INC. | $121.54 | 2019-2020 | |
| Pbg Puerto Rico LLC | $71.31 | 2019-2022 | |
| Boston Scientific Corporation | $40.00 | 2019-2022 | |
| Terumo Medical Corporation | $31.16 | 2019 | |
| Merck Sharp & Dohme LLC | $24.08 | 2025 | Winrevair |
| Scpharmaceuticals INC. | $20.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Rios Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.